Sally Forrest

Sally Forrest

Auto-generated profile, based on publicly available information

Sally Forrest

The School of Medicine, University of St Andrews, St Andrews, UK

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 September 2021 in medRxiv
Verified
Preprint
Open access
PDF file
AMAndrew Conway Morris
Andrew Conway Morris
KSKatherine Sharrocks
Katherine Sharrocks
RBRachel Bousfield
Rachel Bousfield
LKLeanne Kermack
Leanne Kermack
MMMailis Maes
Mailis Maes
VNVilas Navapurkar
Vilas Navapurkar
Summary: Background: The COVID-19 pandemic has overwhelmed the respiratory isolation capacity in hospitals; many wards lacking high-frequency air changes have been repurposed for managing patients infected with SARS-CoV-2 requiring either standard or intensive care. Hospital-acquired COVID-19 is a recognised problem amongst both patients and staff, with growing evidence for the relevance of airborne transmission. This study examined the effect of air filtration and ultra-violet (UV) light sterilisation on detectable airborne SARS-CoV-2 and other microbial bioaerosols. Methods: We conducted a crossover study of portable air filtration and sterilisation devices in a repurposed ‘surge’ COVID ward and ‘surge’ ICU. National Institute for Occupational Safety and Health (NIOSH) cyclonic aerosol samplers and PCR assays were used to detect the presence of airborne SARS-CoV-2 and other microbial bioaerosol with and without air/UV filtration. Results: Airborne SARS-CoV-2 was detected in the ward on all five days before activation of air/UV filtration, but on none of the five days when the air/UV filter was operational; SARS-CoV-2 was again detected on four out of five days when the filter was off. Airborne SARS-CoV-2 was infrequently detected in the ICU. Filtration significantly reduced the burden of other microbial bioaerosols in both the ward (48 pathogens detected before filtration, two after, p =0.05) and the ICU (45 pathogens detected before filtration, five after p =0.05). Conclusions: These data demonstrate the feasibility of removing SARS-CoV-2 from the air of repurposed ‘surge’ wards and suggest that air filtration devices may help reduce the risk of hospital-acquired SARS-CoV-2. Funding: Wellcome Trust, MRC, NIHR

7 June 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
TBTeresa Brevini
Teresa Brevini
MMMailis Maes
Mailis Maes
GWGwilym J. Webb
Gwilym J. Webb
WGWilliam T. H. Gelson
William T. H. Gelson
SFSally Forrest
Sally Forrest
FSFotios Sampaziotis
Fotios Sampaziotis
Prevention of SARS-CoV-2 entry in cells through the modulation of viral host receptors, such as ACE2, could represent a new therapeutic approach complementing vaccination. However, the mechanisms controlling ACE2 expression remain elusive. Here, we identify the farnesoid X receptor (FXR) as a direct regulator of ACE2 transcription in multiple COVID19-affected tissues, including the gastrointestinal and respiratory systems. We demonstrate that FXR antagonists, including the over-the-counter compound z-guggulsterone (ZGG) and the off-patent drug ursodeoxycholic acid (UDCA), downregulate ACE2 levels, and reduce susceptibility to SARS-CoV-2 infection in lung, cholangiocyte and gut organoids. We then show that therapeutic levels of UDCA downregulate ACE2 in human organs perfused ex situ and reduce SARS-CoV-2 infection ex vivo . Finally, we perform a retrospective study using registry data and identify a correlation between UDCA treatment and positive clinical outcomes following SARS-CoV-2 infection, including hospitalisation, ICU admission and death. In conclusion, we identify a novel function of FXR in controlling ACE2 expression and provide evidence that this approach could be beneficial for reducing SARS-CoV-2 infection, thereby paving the road for future clinical trials.

22 June 2026 in Microbial Genomics
Verified
Journal Article
Open access
SGSarah Gallichan
Sarah Gallichan
TMTommi Mäklin
Tommi Mäklin
EPEsther Picton-Barlow
Esther Picton-Barlow
CMClaudia McKeown
Claudia McKeown
SFSally Forrest
Sally Forrest
JLJoseph M. Lewis
Joseph M. Lewis
Inferring transmission relies on accurately distinguishing between isolates from the same source and those from different sources, and high-quality genomic data are frequently used to model transmission scenarios. The post-enrichment metagenome sequencing (pe-MGS) method uses a sequencing approach to analyse the diversity of a target pathogen enriched by pre-culturing and has been effectively used to analyse the transmission of nosocomial infections. However, a direct comparison of single nucleotide variant (SNV) call accuracy, cost and feasibility between single-colony whole-genome sequence (sc-WGS) data and pe-MGS for an antimicrobial resistant bacteria of clinical importance, extended-spectrum beta-lactamase producing Escherichia coli (ESBL-EC), is required for implementation in large-scale clinical studies. A spiked stool sample and rectal swabs from six study participants were pre-enriched in buffered peptone water and cultured on MacConkey agar with 1 mg l −1 cefotaxime. Seven single colonies were picked, and the remaining biomass of all colonies was collected from each plate, sequenced and analysed using the mSWEEP/mGEMS pipeline. We created a custom SNV calling workflow that allows heterozygous SNVs in a bacterial population and found that the choice of reference changed the number of measurable SNV distances between the sc-WGS and pe-MGS. Using our custom workflow with a core-gene reference captured 99% of all the SNV calls from multiple sc-WGS data in the pe-MGS data of the same culture. The plate sweep method offers a feasible, cost-effective alternative to multiple single colony picks for describing within-host ESBL-EC diversity. The workflow we developed allows for effective SNV calling from pe-MGS data that were comparable to SNV calls from multiple sc-WGS data from the same sample.

3 September 2024 in medRxiv
Verified
Preprint
Open access
PDF file
MJMark Jeffrey
Mark Jeffrey
JSJosefin Bartholdson Scott
Josefin Bartholdson Scott
RWRichard J White
Richard J White
EHEllen Higginson
Ellen Higginson
MMMailis Maes
Mailis Maes
MCMartin D Curran
Martin D Curran
Pneumonia is the leading infectious disease killer worldwide and commonly requires admission to critical care. Despite its prevalence, the underpinning biology of severe pneumonia remains incompletely understood. We performed multifaceted assessments of bronchoalveolar transcriptome, cytokines, microbiology, and clinical features to biologically dissect a cohort of patients with suspected severe pneumonia. Our data revealed three lung-restricted transcriptionally defined severe pneumonia endotypes (termed ‘Pneumotypes’ (Pn)). All three Pneumotypes had comparable clinical presentations and severity of respiratory failure but critically had divergent outcomes. Pn1, the most common, was characterised by low alveolar cytokines, expanded tolerogenic macrophages and epithelial damage. Pn3 was characterised by neutrophil-monocyte infiltration, IL-6-STAT3 activation and longer duration of mechanical ventilation. Pn2 displayed the fastest resolution, exhibiting a balanced immune response and epithelial-endothelial repair signatures. Our work has identified mechanistically distinct phenotypes in the lungs of patients with suspected pneumonia and acute lung injury, providing new targets for personalised therapy.

14 November 2025 in medRxiv
Verified
Preprint
Open access
PDF file
SGSarah Gallichan
Sarah Gallichan
TMTommi Mäklin
Tommi Mäklin
EPEsther Picton-Barlow
Esther Picton-Barlow
CMClaudia McKeown
Claudia McKeown
SFSally Forrest
Sally Forrest
JLJoseph M Lewis
Joseph M Lewis
Inferring transmission relies on accurately distinguishing between isolates from the same source and those from different sources, and high-quality genomic data is frequently used to model transmission scenarios. The post-enrichment metagenome sequencing (pe-MGS) method uses a sequencing approach to analyse the diversity of a target pathogen enriched by pre-culturing, and has been effectively used to analyse the transmission of nosocomial infections. However, a direct comparison of single nucleotide variant (SNV) call accuracy, cost and feasibility between single colony whole genome sequence (sc-WGS) data and pe-MGS for an antimicrobial resistant bacteria of clinical importance, extended-spectrum beta-lactamase producing E. coli (ESBL-EC), is required for implementation in large-scale clinical studies. A spiked stool sample and rectal swabs from six study participants were pre-enriched in buffered peptone water and cultured on MacConkey agar with 1mg/L cefotaxime. Seven single colonies were picked, and the remaining biomass of all colonies was collected from each plate, sequenced and analysed using the mSWEEP/ mGEMS pipeline. We created a custom SNV calling workflow that allows heterozygous SNVs in a bacterial population, and found that the choice of reference changed the number of measurable SNV distances between the sc-WGS and pe-MGS. Using our custom workflow with a core-gene reference captured 99% of all the SNV calls from multiple sc-WGS data in the pe-MGS data of the same culture. The plate sweep method offers a feasible, cost-effective alternative to multiple single colony picks for describing within-host ESBL-EC diversity. The workflow we developed allows for effective SNV calling from pe-MGS data that was comparable to SNV calls from multiple sc-WGS data from the same sample. Abbreviations: AMR, antimicrobial resistance; ESBL-EC, extended-spectrum beta-lactamase producing Escherichia coli ; ST, sequence type; SNV, single nucleotide variant; BPW, buffered peptone water; sc-WGS, single-colony whole-genome sequencing; pe-MGS, post-enrichment metagenome sequencing Impact statement: For bacterial species with high within patient diversity and within-genome variation such as the opportunistic pathogen E. coli , capturing the full diversity is essential to identify transmission events. Pre-enriching the species of interest from patient samples, and then sequencing all colonies, post-enrichment metagenomics (pe-MGS) promises to be a cost-effective, efficient method capturing the full diversity. To estimate transmission events with high confidence and make it applicable for hospital transmission studies, single-nucleotide variants (SNVs) have to be identified with an equivalent resolution as would be achieved when using single-colony whole-genome sequencing on all colonies. Here we present a proof-of-concept study on a set of stool samples and rectal swabs from healthy participants, where we developed a new workflow tested against these control samples. All samples were analysed using both single-colony WGS (sc-WGS) and pe-MGS from the same plate, following pre-enrichment for the species and phenotype of interest (drug resistant Escherichia coli ). This direct comparison allowed us to assess the reconstruction of SNVs between the two approaches on clinically relevant sample types at the highest resolution. We show that by using a newly developed SNV calling workflow, a core-gene reference allowed us to identify comparable SNVs in the pe-MGS to the sc-WGS sequence data. The pe-MGS offers a cheaper and time-saving alternative to multiple sc-WGS and is thus more feasible to integrate into public health settings for routine surveillance. This would provide a robust basis to significantly improve our detection of transmission events and thus understanding of transmission routes, and allow for the targeted implementation of preventative measures. Data summary: The short-read sequence data generated in this study have been submitted to the European Nucleotide Archive (ENA, https://www.ebi.ac.uk/ena/browser/view/PRJEB101999 ), and their individual accession numbers are listed in Supplementary Table 1 . Github repository: https://github.com/joelewis101/TRACS-liverpool/tree/main/bioinformatics . All protocols developed and utilized in this study have been detailed and provided in the article and supplementary data files.

9 October 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
RSRebecca C. Stout
Rebecca C. Stout
HCHelen Callaby
Helen Callaby
SGSarah Gallichan
Sarah Gallichan
AZAllan Zuza
Allan Zuza
SFSally Forrest
Sally Forrest
NFNicholas A. Feasey
Nicholas A. Feasey
Background: The number of people living with multimorbidity, defined as two or more chronic conditions, is rising globally. Chronic, non-communicable diseases and infections are often managed separately, with resource allocation for health services planned accordingly. The interaction between multimorbidity, acute bacterial infection, and antimicrobial resistance (AMR) remains poorly understood. Methods: We searched MEDLINE, EMBASE, Web of Science and CINAHL from inception to 20 Jan 2026 for studies reporting multimorbidity and acute bacterial infection. Outcomes included prevalence of multimorbidity in acute bacterial infection, rate of infection in populations with multimorbidity, and mortality, admission to hospital, and length of hospital stay (LOS). We conducted meta-analyses of multimorbidity prevalence and unadjusted mortality odds ratios (ORs), with sensitivity analysis and meta-regression to explore heterogeneity. Outcomes with inadequate data for meta-analysis were narratively synthesised.Findings: Thirty-six studies from 12,040 screened articles were included. Twenty-one studies including data from 1,392,174 individuals gave a pooled prevalence of multimorbidity in populations with acute bacterial infection of 36% (95% CI 29-45%; I2=100%). Eight studies with 1,003,784 individuals found greater mortality in people with multimorbidity (unadjusted OR 2.20, 95% CI 1.58-3.06; I2 98%). Adjusted mortality estimates were too heterogenous to pool, but consistently indicated increased mortality. Nine studies reported on infection incidence/risk and indicated increased risk with multimorbidity. Few studies reported on how multimorbidity is associated with LOS (n=3), hospital admission (n=2) or AMR (n=2) in individuals with an acute bacterial infection. Interpretation: Multimorbidity is common in individuals with acute bacterial infection and are associated with increased infection and mortality risk. There is currently limited robust and comparable data which represents a significant knowledge gap in the cross-over between infections and chronic diseases, which are often approached in silos. Standardised terminology, definitions and data capture are needed to enable comparability and further investigate these associations.